Skip to content
TrustList
Episode 1 Ventures logo
Investor

Episode 1 Ventures

UK seed-stage investor backing B2B software founders

Episode 1 Ventures cover

About Episode 1 Ventures

Episode 1 Ventures is a seed-stage investor in business software companies based in the United Kingdom. It says it wants to understand what led a founder to their idea and then help build the company around it.

What Episode 1 Ventures offers

  • Seed investment — early money for B2B software start-ups.
  • Hands-on support — help with sales, people and business problems, according to founders quoted on its site.
  • One-to-one attention — close contact between the investors and each founder.

Who it works with

UK-based founders of B2B software companies, often people with deep expertise in the industry they want to change.

Key facts

  • Region: United Kingdom
  • Stage: seed
  • Focus: B2B software

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to Episode 1 Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Episode 1 Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Episode 1 Ventures.

Episode 1 Ventures alternatives

Similar listings buyers compare against this one.

Oregon venture capital fund investing early in minority and women-led startups

European venture capital firm backing founders building global software companies

Austin venture firm funding Texas technology and tech-enabled services companies from pre-seed to Series B

Student-run venture fund backing young Nordic founders at the earliest stage

Boston investment manager running four closed-end healthcare funds listed on the New York Stock Exchange